These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 20832057)

  • 21. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
    Avale ME; Falzone TL; Gelman DM; Low MJ; Grandy DK; Rubinstein M
    Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine.
    Napolitano F; Bonito-Oliva A; Federici M; Carta M; Errico F; Magara S; Martella G; Nisticò R; Centonze D; Pisani A; Gu HH; Mercuri NB; Usiello A
    J Neurosci; 2010 Aug; 30(33):11043-56. PubMed ID: 20720111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function.
    Berridge CW; Devilbiss DM; Andrzejewski ME; Arnsten AF; Kelley AE; Schmeichel B; Hamilton C; Spencer RC
    Biol Psychiatry; 2006 Nov; 60(10):1111-20. PubMed ID: 16806100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioural and neurochemical abnormalities in mice lacking functional tachykinin-1 (NK1) receptors: a model of attention deficit hyperactivity disorder.
    Yan TC; Hunt SP; Stanford SC
    Neuropharmacology; 2009 Dec; 57(7-8):627-35. PubMed ID: 19748515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of 'binge' cocaine administration on the expression of cyclin-dependent kinase 5 and its activator p35 in various regions of rat brain.
    Wedzony K; Markowicz-Kula K; Chocyk A; Fijał K; Maćkowiak M
    Brain Res; 2005 Nov; 1063(2):195-200. PubMed ID: 16263094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prepuberal intranasal dopamine treatment in an animal model of ADHD ameliorates deficient spatial attention, working memory, amino acid transmitters and synaptic markers in prefrontal cortex, ventral and dorsal striatum.
    Ruocco LA; Treno C; Gironi Carnevale UA; Arra C; Mattern C; Huston JP; de Souza Silva MA; Nikolaus S; Scorziello A; Nieddu M; Boatto G; Illiano P; Pagano C; Tino A; Sadile AG
    Amino Acids; 2014 Sep; 46(9):2105-22. PubMed ID: 24862315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reward-enhancing effect of methylphenidate is abolished in dopamine transporter knockout mice: A model of attention-deficit/hyperactivity disorder.
    Ide S; Ikekubo Y; Hua J; Takamatsu Y; Uhl GR; Sora I; Ikeda K
    Neuropsychopharmacol Rep; 2018 Sep; 38(3):149-153. PubMed ID: 30175528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity.
    Allen PB; Zachariou V; Svenningsson P; Lepore AC; Centonze D; Costa C; Rossi S; Bender G; Chen G; Feng J; Snyder GL; Bernardi G; Nestler EJ; Yan Z; Calabresi P; Greengard P
    Neuroscience; 2006 Jul; 140(3):897-911. PubMed ID: 16600521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats.
    Ruocco LA; Carnevale UA; Treno C; Sadile AG; Melisi D; Arra C; Ibba M; Schirru C; Carboni E
    Behav Brain Res; 2010 Jun; 210(1):99-106. PubMed ID: 20156489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Negative regulation of cyclin-dependent kinase 5 targets by protein kinase C.
    Sahin B; Hawasli AH; Greene RW; Molkentin JD; Bibb JA
    Eur J Pharmacol; 2008 Mar; 581(3):270-5. PubMed ID: 18190909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of norepinephrine in the control of activity and attentive processes in animal models of attention deficit hyperactivity disorder.
    Viggiano D; Ruocco LA; Arcieri S; Sadile AG
    Neural Plast; 2004; 11(1-2):133-49. PubMed ID: 15303310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences between electrically-, ritalin- and D-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of Attention-Deficit Hyperactivity Disorder.
    Russell V; de Villiers A; Sagvolden T; Lamm M; Taljaard J
    Behav Brain Res; 1998 Jul; 94(1):163-71. PubMed ID: 9708847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylphenidate does not increase ethanol consumption in a rat model for attention-deficit hyperactivity disorder-the spontaneously hypertensive rat.
    Soeters HS; Howells FM; Russell VA
    Metab Brain Dis; 2008 Sep; 23(3):303-14. PubMed ID: 18665438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prefrontal cortex Homer expression in an animal model of attention-deficit/hyperactivity disorder.
    Hong Q; Zhang M; Pan XQ; Guo M; Li F; Tong ML; Chen RH; Guo XR; Chi X
    J Neurol Sci; 2009 Dec; 287(1-2):205-11. PubMed ID: 19709672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
    Prince J
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prefrontal cortex and the caudate nucleus respond conjointly to methylphenidate (Ritalin). Concomitant behavioral and neuronal recording study.
    Venkataraman SS; Claussen CM; Kharas N; Dafny N
    Brain Res Bull; 2020 Apr; 157():77-89. PubMed ID: 31987926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diacylglycerol kinase β knockout mice exhibit attention-deficit behavior and an abnormal response on methylphenidate-induced hyperactivity.
    Ishisaka M; Kakefuda K; Oyagi A; Ono Y; Tsuruma K; Shimazawa M; Kitaichi K; Hara H
    PLoS One; 2012; 7(5):e37058. PubMed ID: 22590645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GIT1 is associated with ADHD in humans and ADHD-like behaviors in mice.
    Won H; Mah W; Kim E; Kim JW; Hahm EK; Kim MH; Cho S; Kim J; Jang H; Cho SC; Kim BN; Shin MS; Seo J; Jeong J; Choi SY; Kim D; Kang C; Kim E
    Nat Med; 2011 May; 17(5):566-72. PubMed ID: 21499268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CDH2 mutation affecting N-cadherin function causes attention-deficit hyperactivity disorder in humans and mice.
    Halperin D; Stavsky A; Kadir R; Drabkin M; Wormser O; Yogev Y; Dolgin V; Proskorovski-Ohayon R; Perez Y; Nudelman H; Stoler O; Rotblat B; Lifschytz T; Lotan A; Meiri G; Gitler D; Birk OS
    Nat Commun; 2021 Oct; 12(1):6187. PubMed ID: 34702855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cdk5/p35 functions as a crucial regulator of spatial learning and memory.
    Mishiba T; Tanaka M; Mita N; He X; Sasamoto K; Itohara S; Ohshima T
    Mol Brain; 2014 Nov; 7():82. PubMed ID: 25404232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.